Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Dexmedetomidine
Drug ID BADD_D00629
Description An agonist of receptors, adrenergic alpha-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of dexmedetomidine.
Indications and Usage For sedation of initially intubated and mechanically ventilated patients during treatment in an intensive care setting, also used in pain relief; anxiety reduction and analgesia
Marketing Status approved; vet_approved
ATC Code N05CM18
DrugBank ID DB00633
KEGG ID D00514
MeSH ID D020927
PubChem ID 5311068
TTD Drug ID D0U3DU
NDC Product Code 55150-209; 81092-1180; 16729-432; 68083-527; 81092-1120; 67457-251; 70860-605; 66794-230; 66794-238; 62068-308; 16729-239; 71288-505; 66794-233; 71872-7150
UNII 67VB76HONO
Synonyms Dexmedetomidine | MPV-1440 | MPV 1440 | MPV1440 | Precedex | Dexmedetomidine Hydrochloride | Hydrochloride, Dexmedetomidine
Chemical Information
Molecular Formula C13H16N2
CAS Registry Number 113775-47-6
SMILES CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Cardiac tamponade02.06.01.0010.000196%
Cardio-respiratory arrest22.02.06.007; 02.03.04.0020.000392%Not Available
Cardiogenic shock24.06.02.006; 02.05.01.0030.000196%Not Available
Cardiovascular disorder24.03.02.009; 02.11.01.010--Not Available
Chills15.05.03.016; 08.01.09.001--
Circulatory collapse24.06.02.0010.000327%Not Available
Coma17.02.09.0010.000131%Not Available
Condition aggravated08.01.03.0040.000327%Not Available
Confusional state19.13.01.001; 17.02.03.005--
Constipation07.02.02.001--
Decubitus ulcer23.03.11.006--Not Available
Delirium19.13.02.001--
Depressed level of consciousness17.02.04.0020.000196%
Dermatitis23.03.04.002--Not Available
Diabetes insipidus14.05.07.003; 05.03.03.0040.000719%Not Available
Diarrhoea07.02.01.001--
Diastolic hypertension24.08.02.006--Not Available
Dizziness02.11.04.006; 24.06.02.007; 17.02.05.003--
Drug ineffective08.06.01.006--Not Available
Drug withdrawal convulsions17.12.03.016; 08.06.02.0030.001241%Not Available
Dry mouth07.06.01.002--
Dysarthria19.19.03.001; 17.02.08.0010.000131%
Dyspnoea02.11.05.003; 22.02.01.004--
Electrocardiogram T wave inversion13.14.05.007--Not Available
Electrolyte imbalance14.05.01.0020.000131%Not Available
Extrasystoles02.03.02.003--Not Available
Extravasation08.01.03.0080.000797%Not Available
Feeling abnormal08.01.09.014--Not Available
Fluid retention20.01.02.003; 14.05.06.002--Not Available
Gamma-glutamyltransferase increased13.03.04.024--
The 2th Page    First    Pre   2 3 4 5 6    Next   Last    Total 7 Pages